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Abstract: This paper presents a study to estimate a preference-based single index from the 
Asthma Quality of Life Questionnaire (AQLQ). Based on the AQL-5D which is a health 
classification system directly derived from AQLQ, 98 health states was valued by a sample 
of 307 members of the UK general population. Models were estimated to predict all 
possible 3125 health states defined by the AQL-5D and compared using a set of criteria. 
The mean model of main effects was recommended of preferable prediction ability and 
logically consistent and significant coefficients for levels of dimensions. However, there 
are concerns over condition-specific valuation issues, such as presenting asthma 
information to general public and the choice of condition specific full health as the upper 
anchor for TTO valuation.
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Introduction 
Cost-effectiveness analysis has been widely used as a tool to support decision making on 
health resource allocation in the last decade, especially with establishment of government 
agencies such as the National Institute for Health and Clinical Excellence (NICE) in the UK 
and similar agencies around the world (ISPOR, 2006). A cost-effectiveness study may 
employ Quality Adjusted Life Years (QALYs) as the outcome measure to enable direct 
comparisons across different health interventions or different medical conditions.
The QALY combines quality of life (expressed in terms of a “utility” score) and length of 
life (in years) into a single index. The utility score reflects the quality of life of a given 
health state and is elicited through valuation exercises, such as the Standard Gamble, Time 
Trade-off (TTO), or the Visual Analogue Scale (VAS). The scores lie on a scale of 0 to 1, 
where 0 is equivalent to dead and 1 equivalent to perfect health. Economic evaluations of 
health care technologies can either carry out their own valuation studies of the health states 
relevant to the given research project, or they can use “off the shelf” generic preference-
based instruments. These instruments have pre-scored health classification system and are 
able to estimate utility scores for all possible health states: examples include EQ-5D (Dolan, 
1997), Health Utility Index (HUI; Feeny et al, 2002), Quality of Well-being Scale (QWB; 
Anderson et al, 1989) and SF-6D (Brazier et al, 2002). Such “off the shelf instruments” 
have been widely used in cost-effectiveness studies not only because of their convenience, 
but also because they improve comparability across studies.
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A clinical trial often includes disease-specific quality of life instruments to capture clinical 
efficacy, and increasingly, one of the generic preference-based instruments in order to 
derive QALYs and to calculate cost effectiveness. Generic preference-based instruments 
typically cover dimensions of health such as mobility, pain, activity limitation, and anxiety 
or depression. However, for certain medical conditions, the set of dimensions covered by 
generic measures may not be relevant, or even where relevant, they have been found to 
insensitive (Guyatt GH, et al, 1999; Jenkinson C, et al, 1997) by missing ‘small but 
important changes’ or requiring a larger sample size for some specific medical conditions. 
At the same time, many clinical trials currently exclude generic measures, either due to 
concerns about patient burden or because they are not regarded as appropriate by those 
designing the trial. This disadvantage evoked the debate on roles of generic and condition-
specific health related measures in health care decision making, (Dowie J, 2002; Feeny D, 
2002; Guyatt G; Brazier J, 2002). 
One way to improve the sensitivity of generic preference-based measures is to broaden 
their coverage to include dimensions relevant to the condition being considered (a condition 
specific ‘add-on’). While this approach is worth exploring, another approach is to obtain 
preference weights for a condition specific descriptive system. This has the advantage that 
it ensures that the health state utility scores used in economic evaluation better reflect the 
impact of the medical condition; and secondly it makes better use of the condition-specific 
measures where generic ones have been excluded. Several studies have been undertaken to 
obtain health state utility values for condition-specific instruments, such as the multi-
attribute Rhinitis Symptom Utility Index (Revicki et al, 1998), the Asthma-Symptom 
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Utility Index (ASUI) (Revicki et al, 1998), the International Index of Erectile Function 
(Stolk et al, 2003), health states related to erectile dysfunction (Torrance et al, 2004) and 
Urinary Incontinence (Brazier et al, 2005).  
There has been little written on the methods for developing a preference-based measure 
from a condition specific measure. The study reported in this paper was undertaken to 
develop a preference-based single index from an asthma-specific instrument.
The Asthma Quality of Life Questionnaire (AQLQ) has been designed to assess health 
related quality of life in patients with asthma (Juniper et al, 1993; also see Juniper et al, 
1999). It has been used in more than 170 papers quoted by Medline. However, the AQLQ 
cannot be directly used in economic evaluation in its current form because it does not 
incorporate preference information. 
To derive a preference-based single index measure from the AQLQ, we used a 
methodology successfully used on the SF-36 by Brazier et al (2002) to generate the SF-6D. 
The first stage is to derive a reduced health state classification system from the AQLQ that 
is amenable to valuation exercises using a preference elicitation technique. The second 
stage is a valuation survey of a selection of states defined by this reduced classification 
system, by a sample of the UK general population. The third stage is to estimate a range of 
econometric models for predicting the health state values for all states defined by the new 
classification system, which in turn will enable the calculation of health state utility values 
for calculating QALYs based on AQLQ data.
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This paper concentrates on the valuation survey and the econometric modelling.  For the 
derivation of the reduced classification system, see Young et al (2005).
The next section describes the AQLQ in more detail. This is followed by a brief description 
of the reduced classification system used in the valuation survey. Section 3 describes the 
methods involving in the valuation survey and modelling. Section 4 presents the results of 
the study including the survey and the models. The final section discusses the results and 
then use of condition specific preference-based measures in informing resource allocation
1. The AQLQ and the reduced classification system
The AQLQ consists of 32 items with 7 levels each, covering 4 dimensions: symptoms (12 
items), activity limitations (11 items), emotional function (5 items) and environmental 
stimuli (4 items). Table 1 shows the 32 items in the AQLQ. 
The original AQLQ is too large to be amenable to valuation. Therefore, based on the 
application of Rasch analysis and conventional psychometric tests, the AQLQ has been 
reduced to a 5- dimension health state classification system which we call AQL-5D (see 
Table 2). The dimensions are: concern about asthma, shortness of breath, weather and 
pollution stimuli, sleep impact and activity limitations. These dimensions are selected 
directly from the original AQLQ. Each dimension has 5 levels of severity with level 1 
denoting no problem and level 5 indicating extreme problem. All AQLQ health states 
which contain those five items can be mapped on to the newly defined AQL-5D.
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2. Methods
2.1 Valuation survey 
The aim of the valuation survey is to elicit preference values from the general public for a 
sample of health states defined by the AQL-5D. The key methodological issues are the 
selection of health state sample to be valued, sampling of respondents and overall size of 
the sample, effective way of presenting asthma disease information to general public, and 
the technique for eliciting preferences. 
2.1.1 Selection of health states  
The selection of health states was determined by the specification of the model to be 
estimated. In this study, 98 health states were selected out of the 3125 possible health states 
defined by the classification. The selection was on the basis of a balanced design, which 
ensured that any dimension-level (level of dimension ) had an equal chance of being 
combined with all levels of the other dimensions. These 98 states were stratified into 
severity groups based on their total level score across the dimensions (simply the sum of 
the levels), and then randomly allocated into 14 blocks, so that each block has 7 health 
states. This procedure ensured that each respondent, who were allocated one of the 14 
blocks, received a set of states balanced in terms of severity and that each state is valued the 
same number of times apart from the worst possible state, or the ‘pits’ state, which is 
valued by all respondents. 
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2.1.2. Respondents 
An important methodological issue is whether to sample a group of patients or use a sample 
of the general population (Drummond et al, 1997). However, health policy bodies such as 
NICE have recommended using general public values. It was decided to elicit the 
preference values of general public although this instrument is a condition specific 
questionnaire.  
The respondents are members of the general population randomly selected using the 
electoral register of names and address from within South Yorkshire, UK. Based on 
previous experience, we decided to interview a sample of 300 participants providing 
valuations for 98 health states, which were deemed sufficient to estimate a reliable additive 
model. 
2.1.3 Pilot study on presentation of asthma information
Given that it might be a problem for members of the general public to imagine what it is 
like to live with asthma, two different ways in which to present information on asthma were 
piloted on 100 respondents selected in the same way though not included in the main 
survey. The first presentation was based on around 180 words of verbal information printed 
on a card (taken from the British Thoracic Society website, see Appendix 1), and the other 
was based on two brief video clips (provided by Asthma UK, and Wellington Asthma 
Research) showing the biological mechanism of asthma and patients with asthma 
symptoms.
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Interviews were undertaken in the same way as in the main valuation survey (see 2.1.5) 
with one “block” containing eight health states. In order to choose one block of health 
states using in the pilot survey, an assumption of logical consistency must be taken: for any 
pair of health states, people should give better rank or higher utility value to state A than for 
B, if A is logically better on at least one dimension and no worse on any other dimension; if 
not, logical consistency is violated. For any block of with eight health states, there are total 
twenty-eight opportunities of pair-wise comparisons but not all of them can be used to test 
logical consistency. The block of health states with the largest potential to violate logical 
consistency were chosen for the pilot study. The effects of different ways to present asthma 
information were examined by comparing the time taken for interview, respondents’ 
understanding for the ranking and TTO tasks, violation of strong consistency in the ranking 
task, and Standard Deviation (SD) of mean TTO values for each health state valued (with 
the narrower SD the better). The results were used to decide which method to use in the 
main survey.
A sample of 99 members of the public was interviewed in the pilot survey. The respondents 
of the verbal information group and the video clip group were comparable in terms of age, 
gender, education status. However, due to small sample size, unbalance existed as the 
verbal group was relatively less healthy comparing to video group, with more asthma 
patients (24/50 comparing to 10/49) and higher self-reported EQ-5D levels. The two groups 
of respondents had similar results in terms of time taken for the interview, respondents’ 
understanding of the ranking and TTO tasks, violation of consistency in the ranking task. 
There was no obvious difference between the standard deviations of the mean TTO values 
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for each health state valued by those two groups. Given that there was no apparent effect on 
respondents’ understanding on asthma information based on these two methods of 
presenting information or the responses they gave, the simpler method of verbal 
presentation was chosen for the main survey. 
2.1.4 Preference elicitation task 
The time trade off (TTO) technique was chosen for eliciting preference values, which asks 
respondents to trade off between length of life and quality of life. This survey used the 
TTO-prop method developed by the York Measurement and Valuation Health Group, 
which uses a ‘time board’ as a visual aid (Gudex, 1994). This version of TTO was selected 
because it has been shown to be more reliable than a non props version (Dolan et al, 1996). 
Furthermore, it has been used to value the EQ-5D. 
2.1.5 Interviews 
Trained interviewers visited and interviewed respondents at their home during April, 2005.  
The interviews consisted of five stages: 
1. Self-reported health in EQ-5D. 
2. Part A: self-reported health in AQL-5D for those respondents who replied they have 
asthma; 
Part B: fill in the AQL-5D, imagining that they had asthma, for those respondents 
who replied they do not have asthma 
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These were mainly warm up tasks to help familiarise the respondent with the 
descriptive system. 
3. Ranking task of 7 intermediate AQLQ health states, full health (AQL-5D health 
state 11111), worst health state defined by the AQL-5D (‘pits’ state 55555) and 
immediate death. Again, this was being used a warm up tasks to help respondent 
understand the notion of the relative preference for different health states 
4. TTO valuation of the 7 intermediate AQL-5D health states and ‘pits’. The upper 
anchor of the TTO exercise is 11111. 
5. Questions on respondent background characteristics 
2.2 Modelling health state values 
2.2.1 The main models
The overall aim of modelling is to predict values for all health states described by the AQL-
5D. The data from these types of valuation surveys are typically skewed and are truncated 
at one.  Furthermore, they will be clustered by respondent as respondents did not value the 
same set of states. Although the allocation of states to respondents was essentially random, 
differences between health state values may be partly due to differences in the preferences 
of the respondents, rather than the dimensions of those states.  
A number of alternative models were explored for predicting the TTO scores generated in 
the valuation survey (taken from Brazier et al, 2002). The general model is:
ijjijijij gy )( zrx (1) 
11 
where i = 1, 2, …, n represents individual health state values and j = 1,2, …, m represents 
respondents. The dependent variable, yij, is the TTO score for health state i valued by 
respondent j. x is a vector of binary dummy variables (x ) for each level of dimension 
of the classification. Level = 1 acts as the baseline for each dimension. z is a vector of 
personal characteristics, which is examined in terms of respondent’s gender, age and 
asthma condition in this paper. The r term is a vector of terms to account for interactions, 
which are examined in terms of interactions between the levels of different dimensions. g is 
a function specifying the appropriate functional form. ij is an error term whose 
autocorrelation structure and distributional properties depend on the assumptions 
underlying the particular model used.
The starting point is individual level models treating each observation as an independent 
value. The first approach is an OLS estimation of model (1), with g as a linear. Possible 
improved specifications, which take account of variation both within and between 
respondents, are the one-way error components random effects model and fixed-effects 
model. Hausman’s test is used to make a choice between those two specifications.  
Estimation is via generalized least squares (GLS) or maximum likelihood estimation 
(MLE). The second approach is at the aggregate level, and aggregate level models are 
estimated based on the mean TTO value of each health state using OLS estimation. For 
this approach, the j subscript and the z vector are dropped from equation (1) above. The 
third approach is the inclusion of interaction terms.  There is evidence that preferences for 
different dimensions of health may not be additive.  Therefore it is important to try to 
estimate interactions. Adapting the approach used in other studies (Brazier et al, 2002), an 
12 
interaction variable C3_2 was created as a dummy variable which takes a value of 1 if two 
or more dimensions in the health state are at level 4 or 5, and 0 otherwise.
To avoid negative values, all models were estimated using a dependent variable defined as 
dis_tto (1- TTO). Given 1 denotes full health; this variable dis_TTO indicates the extent to 
which a given health state moves away from full health. Thus, the more sever the ill health 
state, the greater the coefficient should be, and the expected signs of the dummy 
coefficients should be positive.  
Given the fact that we used AQL-5D full health 11111 as our upper anchor for TTO, the 
choice of the best model should be between models without a constant term1. This is due to 
the fact that we do not have AQL-5D 11111 valued against some generic full health such as 
“no health problems at all”. If AQL-5D 11111 had been valued against generic full health, 
then AQL-5D 11111 can be represented by the intercept term and the best model can be 
selected using the with-constant model. Thus the choice of the best model is based on 
theoretical concerns, rather than the empirical performance though other performance 
criteria are helpful. For instance, models
1 When models are estimated using dis_TTO as dependent variable, the choice of model should be between 
models without constant. This is equivalent to models estimated using TTO as dependent variable, where 
constants are forced to be 1 as full health.
were compared (where available) in terms of their overall diagnosis by adjusted R squared, 
goodness of fit, likelihood ratio, the size and significance of individual parameter estimates, 
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as well as their predictive ability by mean absolute errors (MAE) and T-test between 
observed and predicted values and the numbers of errors greater than 0.05 and 0.10 in 
absolute value. Plots was used to illustrate possible pattern of predict errors. Treating health 
state values as time series data sorting by observed values, Ljung-box test was used to test 
autocorrelation in the prediction errors of models observed mean health state values.
All modelling was carried out using STATA 9.0 and SPSS 12.0 for Windows. 
2.2.2 The effect of respondent characteristics
In order to explore the effect of basic respondent characteristics, age and gender were 
included in the OLS model identified above. The reason to choose the OLS model was that 
it performed better in terms of predictive ability compared with the Random Effects model 
although both of them were estimated at individual level. Age was represented as six 
groups ranging from the 18 to 25 years old as the baseline up to the over 66 group (see 
table 3), gender was represented by a male dummy. 
In addition, it was noted at the pilot stage that a significant proportion of respondents 
reported having experience of asthma themselves (17.2%). Therefore, an additional 
analyse was included in the main survey, to explore the effect of the respondents’ 
experience of asthma. This was explored by adding a dummy representing whether or not 
the respondent has asthma to the OLS model, with ‘having asthma’ as the baseline. The 
sign and the significance of this asthma dummy itself, and the extent to which the other 
coefficients were affected by its inclusion were the focus of interest. 
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3. Results 
3.1 Main valuation survey 
3.1.1 Respondents  
A sample of 307 members of the general population (response rate 40%) from South 
Yorkshire was interviewed. They were all included in the final dataset for analysis. This 
sample was proved to be a representative sample of the UK general population in terms of 
age and gender. The description of the sample is shown in Table 3. Among the respondents, 
more than half are female, between 36 to 65 years old, married or living with partner, and 
experienced serious illness in their family. In this sample, 17.3% have asthma, 22.5% 
respondents have a degree or equivalent, and 45.6% respondents received full-time 
education after 17. The self-reported EQ-5D scores of the respondents by sex are also 
shown in table 3, which are slightly lower than the UK population norms with 0.86 for 
males and 0.85 for females. 
3.1.2 Health state values 
In all there were 2455 health state valuations generated by the respondents. Average 
number of valuations per intermediate health state was 22 (range from 19 to 22) where as 
the ‘pits’ state (AQL-5D state 55555) was valued 307 times, by every respondent. The 
mean health state values ranged from 0.39 to 0.94 and generally have fairly large standard 
deviations (around 0.2 to 0.4). The distribution of the values was negatively skewed. Table 
4 presents health valuation values in blocks 1 to 7 as examples (results of remaining states 
are available from the corresponding author on request). 
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3.2 Modelling 
3.2.1 The main regression results
The results of modelling are presented in Table 5, with summary statistics for internal 
sample predictions presented in the lower half of the table. Models (1) to (4) were estimated 
at the individual level while models (5) to (7) were mean models estimated at the aggregate 
level. Models were estimated on the basis of the main effects dummies except those with 
the interaction variable C3_2. A fixed effects model was not present here as Hausman’s test 
suggested random effects rather than fixed effects model. 
For theoretical reasons, ‘the best model’ should be chosen between models that exclude the 
constant term. Thus all models were estimated without constant terms. Among those 
models estimated, individual level models (1) and (2) have no inconsistencies within 
significant coefficients, whereas mean model (5) has 2. The number of significant 
coefficients among models is comparable (range from 13 to 15). Given different 
observation basis, the adjusted R2 values between individual models and mean models are 
not comparable with each other.  In terms of prediction ability, model (1) and model (5) 
performed equally well with comparable MAE (0.048 vs. 0.047), numbers of absolute 
residuals larger than 0.05 (39 vs. 35) and 0.10 (6 vs. 9), while model (3) performed worse 
than them with larger MAE (0.057), more residuals larger than 0.05 (42) and 0.10 (19).
Ljung-Box test has been used to test autocorrelation between errors. The results showed 
that there were no significant autocorrelation between errors in models (1), (3) and (5). 
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Introduction of interaction term C3_2 in the main effects models resulted in models (2), (4) 
and (7). The coefficients for C3_2 term were non-significant for models (2) and (7), while 
significant for model (4) with a negative sign. However, inclusion of C3_2 did not result in 
appreciable change to the size of the main effects coefficients, nor any improvement of 
prediction ability. In fact, the residual T-test for models (2) and (3), and the LB test for 
model (4) became significant while main effects model were non-significant. Thus, the 
interaction term C3_2 was not to be included in the final model.
Given the main purpose of modelling is to predict mean TTO values of all possible health 
states defined by AQL-5D based on the valuation survey, the predictive ability of models 
was used as the main criteria for model comparison and selection. As a result, the choice of 
model is between model (1) (OLS model) and model (5) (Mean model), which have equally 
good predictive ability. The mean model (5) is chosen as the best model, because health 
state values required in economic evaluation are the average values of specific health states, 
which means the aggregate level rather than the individual level. However, model (5) has 3 
inconsistent coefficients - between breath level 1 as baseline and level 2, between breath 
levels 4 and 5, and between activity levels 4 and 5, so these inconsistent levels were merged 
to improve coefficient consistency, which resulted in model (6). Model (6) is the final 
recommended model for use in future economic evaluations. 
3.2.2 The additional analyses 
Table 6 presents the OLS models before (model (1)) and after (model (8)) covariates 
(having asthma, gender and age) were introduced. While comparing the two models, the 
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adjusted R square did not change remarkably after including covariates (0.522 vs. 0.535). 
Most main effects coefficients showed very minor change at 0.001 level while the 
coefficients within sleep dimension seemed to be most affected.
In model (8), the coefficient for not having asthma is 0.045 (p < 0.05). This indicates that 
asthma patients have lower dis_TTO values than the general public, which means they are 
on average giving higher values to asthma states. The coefficient for gender is 0.048 
(p<0.05). This indicates that females have higher dis_TTO values than males, which means 
they are on average giving lower values to health states. These two coefficients were 
similar in size which may indicates that asthma condition and gender have similar effects 
on the model. Further, the coefficients for age groups ranged from -0.118 to 0.020, with 
groups 26 to 35 and 46 to 55 had negative values and were significant at 0.05 level, which 
indicates that those two age groups in general gave higher values to health states. The 
coefficients of other age groups were non-significant at 0.05 level.
4. Discussion and conclusion 
This paper presents a study to estimate a preference-based single index from a condition 
specific quality of life instrument, using the AQLQ. This means that it is possible to 
convert AQLQ data sets into health state utility values for use in economic evaluations.  
The alleged advantage of condition specific preference-based measures over generic ones is 
that they use a descriptive system that is more relevant and sensitive to the condition.
However, concerns have been expressed in the literature about the appropriateness of 
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condition specific measures for use in making cross programme comparison (Brazier et al, 
2007) 
A related issue is the choice of condition specific full health (AQL-5D state 11111) as 
opposed to generic “full health” as the upper anchor for TTO valuation. Given that it is 
quite possible to conceive of health states that involve no respiratory problems (and hence 
correspond to AQL-5D 11111), and yet involve other health problems (e.g. pain), an 
alternative design would be to use a generic description such as “no health problems” as the 
upper TTO anchor and to directly evaluate AQL-5D 11111 against this and death. The 
difficulty with this is that since the other dimensions of health are not explicitly mentioned, 
it could be confusing to respondents. 
We do not know what respondents were thinking during the interview: did they only think 
about the condition as described by AQL-5D, or did they extend their imagination to other 
aspects of health not included by in the descriptive system, such as depression or pain. 
Respondents might imagine that other dimensions are either at their best level, or some 
level constant between AQL-5D states (such as their current health), then provided there 
are no interactions between those states that are included in the AQL-5D and those 
dimensions excluded from its descriptive system, then this should not matter. However, 
there is a good chance that there are interactions between these dimensions, and without 
further data we can not know how important these are likely to be. In addition, if the levels 
given to these other dimensions of health were related to the main asthma specific 
dimensions of health (e g. no pain and not depressed for the mild asthma states, but severe 
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pain and very depressed for the severe asthma states), then this would also have 
implications for the final health state values 
On more specific design issues, the selection of the health state sample for valuation and 
modelling was based on balanced design regardless of the prevalence of health state in 
population, which may cause difficulty for respondents to imagine those health states 
happened rarely in real life. We checked the feasibility of the states and none seemed to 
cause any problems for respondents. Further, the sample size of over 300 might be thought 
to be small compared the original EQ-5D valuation survey with a sample of 3000, given the 
AQL-5D descriptive system defines 13 times more health states than the EQ-5D. We were 
limited by resource constraints since the collection of stated preference data by interview is 
expensive. However, in terms of MAE, the results are both around 0.05 and the chosen 
model did not suffer from many inconsistencies. A larger sample size with more states 
may have allowed us to estimate significant interaction terms, but the additive model 
seemed to perform satisfactorily against conventional statistical tests
The additional regression analyses introduce covariance of gender, age and asthma 
condition into the OLS model. Although the coefficients of the main effects variables 
mainly remain unchanged, the gender variable is statistically significant. Two age groups 
are also significantly different from the reference age group (18 to 25), which indicates that 
older people of specific age group were giving higher values. Nevertheless, these results 
imply potential influence of respondents’ personal characteristics.
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The impact of patients’ asthma condition to health state valuation has also been examined 
by using a variable to represent whether or not the respondent has asthma in the OLS 
models. This resulted in the coefficients being significant and being positive in the model.
This indicates that there was statistically significant difference between the way 
respondents with and without asthma valued the hypothetical asthma states. Further, 
respondents with asthma valued the hypothetical asthma states higher than those without 
asthma, which has been confirmed by findings elsewhere (e.g. Dolan and Roberts, 2004). 
The possible explanation may be that asthma patients have adapted the condition although 
they know better of the condition than non-patients. These findings are similar to paper on 
EQ-5D and SF-6D found gender, age and health status did have significant impact though 
usually quite modest compared to the descriptive system. (Dolan and Roberts, Kharoubi et 
al, 2007) 
Given people with asthma gave different values; this does raise of the question of the extent 
to which the general public understood the impact of the condition as discussed below. 
Since the preference indices for a specific medical condition was valued by members of the 
general public, one concern is the extent to which the majority of respondents who have no 
direct experience of asthma managed to understand and to imagine what it is like to live 
with asthma.
For informing resource allocation purposes, most agencies require values from a 
representative population and so this is not relevant. However, we did undertake a pilot 
study to examine the impact of two ways of explaining the condition to people and found it 
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had no effect. However, this study found that asthma condition does have an impact on the 
final results.  
In conclusion, this paper is one of the first to present the results from a study to derive a 
condition-specific preference-based measure from an existing measure of health related 
quality of life.  While the study has been a technical success, it does raise some important 
policy issues about the use of preference-based condition specific measures compared to 
generic measures and the role of covariates.
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 Table 1:    Standardized AQLQ items (taken from Juniper, 1993) 
Item No. Question (during the last 2 weeks) as a result of your asthma Domain Wording 
1 Limited strenuous activities Activity Limitations 
2 Limited moderate activities Activity Limitations 
3 Limited social activities Activity Limitations 
4 Limited work-related activities Activity Limitations 
5 Limited sleeping Activity Limitations 
6 How much discomfort or distress as a result of chest tightness Symptoms Quantity 
7 Feel concerned about having asthma Emotional Time 
8 Feel short of breath as a result of your asthma Symptoms Time 
9 Experience asthma symptoms as a result of being exposed to cigarette 
smoke 
Environment Time 
10 Experience a wheeze in your chest Symptoms Time 
11 Feel you had to avoid a situation or environment because of cigarette 
smoke 
Activity Time 
12 How much discomfort or distress have you felt as a result of coughing Symptoms Quantity 
13 Feel frustrated as a result of your asthma Emotional Time 
14 Experience a feeling of chest heaviness Symptoms Time 
15 Feel concerned about the need to use medication for your asthma Emotional Time 
16 Feel the need to clear your throat Symptoms Time 
17 Experience asthma symptoms as a result of being exposed to dust Environment Time 
18 Experience difficulty breathing out as a result of your asthma Symptoms Time 
19 Feel you had to avoid a situation or environment because of dust Activity Time 
20 Wake up in the morning with asthma symptoms Symptoms Time 
21 Feel afraid of not having your asthma medication available Emotional Time 
22 Feel bothered by heavy breathing Symptoms Time 
23 Experience asthma symptoms as a result of the weather or air pollution 
outside 
Environment Time 
24 Were you woken at night by your asthma Symptoms Time 
25 Avoid or limit going outside because of the weather or air pollution Activity Time 
26 Experience asthma symptoms as a result of being exposed to strong 
smells or perfume 
Environment Time 
27 Feel afraid of getting out of breath Emotional Time 
28 Feel you had to avoid a situation of environment because of strong smells 
or perfume 
Activity Time 
29 Has your asthma interfered with a good night’s sleep Symptoms Time 
30 Have a feeling of fighting for air Symptoms Time 
31 How much has your range of activities you would like to have done been 
limited by your asthma
Activity Limitations 
32 Among all the activities you have done how limited have you been by your 
asthma 
Activity Limitations 
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Table 2 the reduced asthma quality of life classification (AQL-5D) 
CONCERN 
1. Feel concerned about having asthma none of the time. 
2. Feel concerned about having asthma a little or hardly any of the time. 
3. Feel concerned about having asthma some of the time. 
4. Feel concerned about having asthma most of the time. 
5. Feel concerned about having asthma all of the time. 
SHORT OF BREATH 
1. Feel short of breath as a result of asthma none of the time. 
2. Feel short of breath as a result of asthma a little or hardly any of the time. 
3. Feel short of breath as a result of asthma some of the time. 
4. Feel short of breath as a result of asthma most of the time. 
5. Feel short of breath as a result of asthma all of the time.
WEATHER & POLLUTION 
1. Experience asthma symptoms as a result of air pollution none of the time. 
2. Experience asthma symptoms as a result of air pollution a little or hardly any of the time. 
3. Experience asthma symptoms as a result of air pollution some of the time. 
4. Experience asthma symptoms as a result of air pollution most of the time. 
5. Experience asthma symptoms as a result of air pollution all of the time. 
SLEEP 
1. Asthma interferes with getting a good night’s sleep none of the time. 
2. Asthma interferes with getting a good night’s sleep a little or hardly any of the time. 
3. Asthma interferes with getting a good night’s sleep some of the time. 
4. Asthma interferes with getting a good night’s sleep most of the time. 
5. Asthma interferes with getting a good night’s sleep all of the time. 
ACTIVITIES 
1. Overall, not at all limited with all the activities done. 
2. Overall, a little limitation with all the activities done. 
3. Overall, moderate or some limitation with all the activities done. 
4. Overall, extremely or very limited with all the activities done. 
5. Overall, totally limited with all the activities done. 
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  Table 3 Characteristics of respondents in evaluation survey (N=307) 
Count Percentage 
Age
18- 34 11.1 
26- 57 18.6 
36- 61 19.9 
46- 50 16.3 
56- 45 14.7 
66- 60 19.5 
Female 168 54.7 
Have asthma 53 17.3 
Married or living with partner 214 69.8 
Experienced serious illness:
in family 194 63.4 
themselves 94 30.6 
Degree or equivalent 69 22.5 
Education after 17 140 45.6 
Renting property 64 20.8 
Found valuation task difficult:
very difficult 24 7.9 
quite difficult 82 26.7 
  Neither difficult nor easy 52 16.9 
Self-reported EQ-5D score male female 
Respondent sample 0.83 0.84 
 UK population 0.85 0.86 
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Table 4 Descriptive statistics for AQL-5D health state values (blocks 1 to 14) 
c bloc N Mean Std. Deviation Median Minimum Maximum
15311 1 21 0.763 0.239 0.800 0.375 1.000 
25313 1 21 0.783 0.206 0.825 0.375 1.000 
32235 1 21 0.793 0.221 0.825 0.375 1.000 
41322 1 21 0.861 0.173 0.925 0.525 1.000 
42245 1 21 0.708 0.322 0.825 -0.275 1.000 
42325 1 21 0.792 0.221 0.825 0.300 1.000 
54245 1 21 0.648 0.311 0.700 -0.225 1.000 
23235 2 23 0.747 0.213 0.825 0.375 1.000 
25112 2 23 0.768 0.183 0.800 0.500 1.000 
33132 2 23 0.861 0.178 0.925 0.375 1.000 
42214 2 23 0.738 0.218 0.800 0.325 1.000 
43234 2 23 0.705 0.265 0.725 0.075 1.000 
51454 2 23 0.588 0.391 0.700 -0.375 1.000 
54333 2 23 0.715 0.225 0.775 0.375 1.000 
15131 3 19 0.785 0.218 0.825 0.375 1.000 
24422 3 19 0.720 0.299 0.825 0.000 1.000 
31155 3 19 0.582 0.376 0.675 -0.300 1.000 
31531 3 19 0.726 0.334 0.925 0.000 1.000 
32435 3 19 0.688 0.288 0.750 0.000 1.000 
34554 3 19 0.488 0.413 0.475 -0.450 1.000 
42542 3 19 0.708 0.294 0.825 0.000 1.000 
13251 4 23 0.843 0.252 0.950 0.000 1.000 
15251 4 23 0.814 0.259 0.994 0.000 1.000 
15355 4 23 0.597 0.477 0.725 -0.950 1.000 
25425 4 23 0.578 0.485 0.675 -0.975 1.000 
41211 4 23 0.872 0.201 1.000 0.500 1.000 
41442 4 23 0.825 0.271 0.992 0.000 1.000 
51451 4 23 0.767 0.311 0.925 0.000 1.000 
12144 5 25 0.706 0.280 0.775 0.025 1.000 
14225 5 25 0.756 0.255 0.825 0.000 1.000 
21223 5 25 0.814 0.271 0.925 0.000 1.000 
35422 5 25 0.748 0.225 0.875 0.350 1.000 
45553 5 25 0.584 0.498 0.675 -0.950 1.000 
51522 5 25 0.818 0.249 0.925 0.175 1.000 
53532 5 25 0.737 0.416 0.925 -0.950 1.000 
12314 6 21 0.665 0.426 0.825 -0.775 1.000 
24133 6 21 0.698 0.238 0.625 0.375 1.000 
34254 6 21 0.473 0.426 0.500 -0.500 1.000 
34351 6 21 0.671 0.373 0.775 -0.475 1.000 
45532 6 21 0.640 0.516 0.875 -0.725 1.000 
51214 6 21 0.673 0.384 0.825 -0.375 1.000 
54123 6 21 0.738 0.337 0.875 -0.475 1.000 
12543 7 24 0.745 0.247 0.725 0.025 1.000 
13321 7 24 0.845 0.239 0.950 0.025 1.000 
25421 7 24 0.790 0.263 0.900 0.000 1.000 
25543 7 24 0.631 0.335 0.713 -0.275 1.000 
32412 7 24 0.841 0.172 0.912 0.500 1.000 
44135 7 24 0.613 0.365 0.650 -0.375 1.000 
53242 7 24 0.748 0.221 0.738 0.025 1.000 
11233 8 21 0.836 0.205 0.925 0.275 1.000 
14341 8 21 0.730 0.243 0.800 0.125 1.000 
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14444 8 21 0.529 0.451 0.575 -0.875 1.000 
23154 8 21 0.714 0.276 0.800 0.000 1.000 
33323 8 21 0.818 0.227 0.900 0.275 1.000 
42554 8 21 0.571 0.457 0.725 -0.825 1.000 
54152 8 21 0.701 0.382 0.875 -0.500 1.000 
21332 9 19 0.850 0.221 0.925 0.400 1.000 
22242 9 19 0.801 0.237 0.900 0.225 1.000 
24433 9 19 0.715 0.305 0.825 0.025 1.000 
32441 9 19 0.833 0.256 0.925 0.075 1.000 
44114 9 19 0.562 0.513 0.725 -0.950 1.000 
45143 9 19 0.704 0.301 0.725 0.025 1.000 
45253 9 19 0.663 0.446 0.725 -0.775 1.000 
13431 10 25 0.798 0.228 0.900 0.200 1.000 
21113 10 25 0.885 0.133 0.925 0.450 1.000 
23534 10 25 0.633 0.286 0.625 0.000 1.000 
41125 10 25 0.685 0.248 0.725 0.000 1.000 
41153 10 25 0.733 0.308 0.800 -0.400 1.000 
53325 10 25 0.540 0.381 0.575 -0.300 1.000 
53525 10 25 0.467 0.419 0.500 -0.700 1.000 
13514 11 23 0.691 0.265 0.700 0.125 1.000 
24335 11 23 0.629 0.278 0.650 0.000 1.000 
31143 11 23 0.805 0.201 0.875 0.325 1.000 
41112 11 23 0.891 0.164 0.950 0.425 1.000 
45341 11 23 0.769 0.273 0.875 0.075 1.000 
52444 11 23 0.699 0.214 0.700 0.300 1.000 
53411 11 23 0.827 0.192 0.925 0.375 1.000 
23312 12 21 0.937 0.105 1.000 0.600 1.000 
24352 12 21 0.875 0.175 0.925 0.325 1.000 
33511 12 21 0.900 0.135 1.000 0.500 1.000 
33552 12 21 0.849 0.194 0.925 0.300 1.000 
52112 12 21 0.934 0.127 1.000 0.525 1.000 
52314 12 21 0.855 0.201 0.925 0.325 1.000 
55424 12 21 0.780 0.220 0.825 0.375 1.000 
13434 13 20 0.586 0.407 0.700 -0.575 1.000 
15331 13 20 0.830 0.166 0.825 0.525 1.000 
24524 13 20 0.486 0.500 0.563 -0.575 1.000 
35453 13 20 0.614 0.387 0.625 -0.375 1.000 
41123 13 20 0.805 0.313 0.912 -0.425 1.000 
52141 13 20 0.840 0.314 0.963 -0.375 1.000 
55521 13 20 0.578 0.459 0.688 -0.475 1.000 
11445 14 22 0.696 0.235 0.713 0.225 1.000 
12511 14 22 0.819 0.228 0.938 0.375 1.000 
15553 14 22 0.701 0.376 0.800 -0.475 1.000 
31215 14 22 0.712 0.257 0.763 0.225 1.000 
32414 14 22 0.672 0.357 0.787 -0.400 1.000 
33245 14 22 0.717 0.264 0.750 0.225 1.000 
34225 14 22 0.641 0.367 0.675 -0.475 1.000 
55555 1~14 307 0.390 0.450 0.425 -0.975 1.000
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Table 5 Main models Estimated
Individual models Mean models 
Dimension 
levels
OLS 
(1) 
OLS+C3_2 
(2) 
RE 
(3) 
RE+C3_2 
(4) 
mean  
(5) 
Mean1 
(6) 
mean+C3_2 
(7) 
_Iconcern_2 0.028 0.027 0.028 0.029 0.027 0.027 0.027 
_Iconcern_3 0.045 0.044 0.044 0.045 0.047 0.046 0.046 
_Iconcern_4 0.062 0.076 0.054 0.073 0.064 0.064 0.073 
_Iconcern_5 0.077 0.087 0.081 0.096 0.064 0.064 0.074 
_Ibreath_2 -0.004 -0.002 0.001 0.006 -0.003 -0.001 
_Ibreath_3 0.027 0.034 0.037 0.046 0.028 0.030 0.032 
_Ibreath_4 0.102 0.122 0.102 0.126 0.107 0.12 
_Ibreath_5 0.111 0.119 0.117 0.128 0.104 0.106 0.111 
_Ipollutio~2 0.009 0.008 0.019 0.018 0.015 0.013 0.013 
_Ipollutio~3 0.027 0.027 0.05 0.053 0.029 0.028 0.028 
_Ipollutio~4 0.055 0.069 0.058 0.074 0.057 0.058 0.067 
_Ipollutio~5 0.12 0.127 0.121 0.128 0.112 0.113 0.12 
_Isleep_2 0.036 0.046 -0.018 -0.01 0.044 0.041 0.049 
_Isleep_3 0.053 0.055 -0.009 -0.01 0.058 0.056 0.059 
_Isleep_4 0.071 0.091 0.033 0.057 0.076 0.073 0.089 
_Isleep_5 0.097 0.113 0.055 0.074 0.091 0.090 0.104 
_Iactivity_2 0.01 0.01 0.04 0.038 0.011 0.011 0.01 
_Iactivity_3 0.064 0.064 0.06 0.06 0.064 0.065 0.064 
_Iactivity_4 0.182 0.197 0.176 0.195 0.183 0.194 
_Iactivity_5 0.187 0.196 0.197 0.206 0.17 0.177 0.18 
C3_2 n/a -0.044 n/a -0.052 n/a -0.031 
N 2456 2456 2456 2456 99     99 99 
Inconsistencies 0 1 0 NA 2  0 2 
Significant 
coefficients 
13 14 15 15 13     11 14 
R2 0.522 0.522 n/a n/a 0.948   0.957 0.948 
MAE 0.048 0.046 0.057 0.055 0.047   0.048 0.046 
N>= 0.05 39 32 42 44 35  32 31 
N>= 0.10 6 10 19 15 9 9 9 
T(mean = 0) 0.483 0.528 3.920 0.036 b b  b 
LB 4.072 5.513 14.206 21.270 5.313   5.768 6.149 
 Note:
All models used dis_tto as dependent variable. All models were estimated without constant 
Estimates shown in bold are significant at P0.05 
C3-2 is an interaction term with 1 denoting two or more dimensions in a health states greater than level 4, 0 otherwise. 
Inconsistency: count for significant coefficients 
b: Mean error is zero by definition 
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Table 6 OLS model with covariates 
OLS
(1) (8)
_Iconcern_2 0.028 0.019
_Iconcern_3 0.045 0.038
_Iconcern_4 0.062 0.051
_Iconcern_5 0.077 0.074
_Ibreath_2 -0.004    -0.010
_Ibreath_3 0.027 0.022
_Ibreath_4 0.102 0.098
_Ibreath_5 0.111 0.105
_Ipollutio~2 0.009    -0.000
_Ipollutio~3 0.027 0.020
_Ipollutio~4 0.055 0.041 
_Ipollutio~5 0.12 0.114
_Isleep_2 0.036 0.032
_Isleep_3 0.053 0.046
_Isleep_4 0.071 0.060
_Isleep_5 0.097 0.087
_Iactivity_2 0.01 0.009
_Iactivity_3 0.064 0.066
_Iactivity_4 0.182 0.185
_Iactivity_5 0.187 0.189
Non- asthma - 0.045 
female - 0.048
26- - -0.118 
36- -    -0.037
46- -    -0.076
56- - 0.000
66- - 0.020
N 2456 2448
Adjusted R2 0.522 0.535
All models used dis_tto as dependent variable. All models were estimated without constant 
Estimates shown in bold are significant at P0.05 
N:  observation number 
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Appendix 1: the information on asthma shown to respondents 
What is asthma?
Asthma is a condition that affects the airways - the small tubes that carry air in and out of the lungs. If you have 
asthma your airways are almost always sensitive and inflamed. 
When you come in to contact with something you are allergic to, or something that irritates your airways (a trigger), 
you airways will become narrower, making it harder to breathe.  The muscles around the walls of your airways 
tighten.  The lining of the airways becomes inflamed and starts to swell and often sticky mucus or phlegm is 
produced.  This will lead to you experiencing asthma symptoms.  
Asthma symptoms can vary. You may find that you start to cough or wheeze, get short of breath, or have a tight 
feeling in your chest.  Despite what many people think, wheezing does not always occur. In fact, coughing is the most 
common asthma symptom. 
Asthma can start at any age.  Some people get symptoms during childhood which then disappear in later life.  Others 
develop ‘late-onset’ asthma in adulthood, without ever having had symptoms as a child. 
   Taken from the British Thoracic Society (BTS) website 
Appendix 2:  
Estimating a single utility index from the Mini Asthma Quality of Life 
Questionnaire (MiniAQLQ) using the AQL-5D  
 
 
The MiniAQLQ has been developed and fully validated by Professor Juniper and her 
colleagues,  who has also developed the Asthma Quality Life Questionnaire (AQLQ), in 
response to a demand for a shorter, standardized version for large clinical trials and for 
managed care monitoring (Juniper et al, 1999). This instrument has 15 items and each 
item has the same 7 severity levels as the original AQLQ. The items are in the same 
domains as the original AQLQ (5 items for the symptoms domain, 4 items for the 
activities domain, 3 items for the emotions domain and 3 items for the environment 
domain). Most items are identical to the corresponding items of the original AQLQ 
although some items have slightly different wording. The MiniAQLQ has very good 
reliability, cross-sectional validity, responsiveness and longitudinal validity (Juniper et al, 
1999). 
 
Although the AQL-5D was derived from the AQLQ, given the large overlap between the 
AQLQ and the MiniAQLQ questionnaires, the AQL-5D can also be used to derive utility 
indices from MiniAQLQ data. Four of the 5 AQL-5D dimensions (concern, short of 
breath, weather & pollution dimensions) have identical MiniAQLQ items. In terms of the 
activity limitation dimension, the AQL-5D question (item 32 of AQLQ) asks about 
limitations in all activities that the respondent has undertaken in the last 2 weeks. While 
there are 4 items relating to activity limitation in the MiniAQLQ, none of them ask the 
same question. They ask how asthma limited respondents in the last 2 weeks doing 
different activities: strenuous activities (item 12), moderate activities (item 13), social 
activities (item 14) and work-related activities (item 15).  
 
In this appendix, 4 different approaches for specifying a level of the AQL-5D activity 
dimension based on the MiniAQLQ activities items are compared.  
1. Average of items 13-15 rounded up; 
2. Average of item 12-15 rounded up; 
3. Take item 13 as is; 
4. Take the worst item from items 13 -15. 
Averages are rounded up in approaches 1 and 2 because the AQL-5D algorithm is only 
applicable to round numbers.   
 
Since item 12 (limited strenuous activity) may not represent the level of a respondent’s 
overall activity limitation, this item was only considered in approach 2. Among these 4 
approaches, approach 1 took moderate, social and work-related activity limitation into 
account and we believe is the most appropriate way to obtain the activity dimension of 
AQL-5D from the MiniAQLQ.  Three other approaches were developed to test the 
sensitivity of the utility values to different assumptions. 
 
The 4 approaches have been applied to the baseline data of a trial containing MiniAQLQ 
(Lloyd et al, 2007).  Table 1 reports AQL-5D health state values resulting from the 4 
approaches. The results show little difference between values which range from 0.787 
(approach 4) to 0.802 (approach 1). In terms of distribution of values, the median and 20 
percentiles resulting from these 4 approaches are also very close to each other.   
 
      Table 1 Description for health state values resulting from 4 approaches 
 
 Approach 1 Approach 2 Approach 3 Approach 4 
N 106 106 106 106 
Mean 0.802 0.794 0.798 0.787 
Median 0.826 0.822 0.822 0.807 
Std. Deviation 0.131 0.134 0.130 0.131 
Minimum 0.450 0.450 0.450 0.450 
Maximum 0.970 0.970 0.970 0.970 
20 0.714 0.698 0.698 0.690 
40 0.794 0.790 0.790 0.777 
60 0.863 0.849 0.859 0.836 
Percentiles 
80 0.922 0.917 0.921 0.913 
 
Pearson correlation coefficients were calculated for utility values resulting from these 4 
approaches (Table 2). Correlation coefficients range from 0.930 to 0.976 and are all 
significant at the 0.01 level. The Intra Class Correlation (ICC) analysis across these 
approaches results in a coefficient as 0.949 and is significant at 0.01 significant level.  
 
Table 2 Correlation coefficients for values resulting from 4 approaches 
 Approach 1 Approach 2 Approach 3 Approach 4 
Approach 1 1.000    
Approach 2 0.976* 1.000   
Approach 3 0.941* 0.942* 1.000  
Approach 4 0.941* 0.930* 0.974* 1.000 
         * Correlation is significant at 0.01 level (2 tailed)  
 
The above analysis shows that results from approach 1 and the other approaches were of 
little difference in terms of mean and median values, as well as distribution of indices. In 
fact, the results were closely correlated as shown by Pearson and ICC correlation 
coefficients. Thus, the approach 1 is recommended as a practical solution.  
  
A SPSS syntax file to calculate utility indices from the MiniAQLQ questionnaire based 
on approach 1 is available from the authors on request.  
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